Curve develops an innovative screening platform.
Curve Therapeutics has raised $51.4M in total funding. The most recent round was Series A. The last funding was announced in February 2024.
Curve Therapeutics's investors include Columbus Venture Partners, Pfizer Venture Investments, Epidarex Capital, British Patient Capital, Advent Life Sciences.
Curve Therapeutics is headquartered in Southampton, United Kingdom.
Curve develops an innovative screening platform.
Curve Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Curve Therapeutics — Funding & Investors." VCBacked, February 27, 2024, https://www.vcbacked.co/company/curve-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Curve Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/curve-therapeutics
{{cite web |title=Curve Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/curve-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated